Consumer Discretionary • Catalog/Specialty Distribution
$4.59 ▲ +0.02
(+0.44%)
MKT CAP: $492.4M • VOL: 1.77M
52W L $2 52W H $6
HNST // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $371.3M | $378.3M | $344.4M |
| YoY Revenue Growth % | -1.9% | +9.9% | — |
| Gross Profit | $123.8M | $144.7M | — |
| Gross Margin % | 33.3% | 38.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$18.5M | -$6.3M | -$38.9M |
| Operating Margin % | -5.0% | -1.7% | -11.3% |
| Net Income (GAAP) | -$15.7M | -$6.1M | -$39.2M |
| EBITDA (Normalized) | -$17.3M | -$5.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $15.1M | $1.5M | $19.4M |
| Capital Expenditures (CapEx) | $1.5M | $530.0K | — |
| Free Cash Flow (FCF) | $13.6M | $1.0M | $19.4M |
| FCF Margin % | 3.7% | 0.3% | 5.6% |
| Return on Invested Capital (ROIC %) | -18.2% | -5.1% | — |
| Cash & Short-Term Equivalents | $89.6M | $75.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $169.7M | $174.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HNST.